HLSE:ORNBVPharmaceuticals
Is Orion Oyj (HLSE:ORNBV) Undervalued Following Strong Earnings And Higher 2026 Guidance?
Orion Oyj earnings jump and guidance raised for 2026
Orion Oyj (HLSE:ORNBV) drew fresh attention after reporting higher second quarter 2026 sales and net income, alongside an updated full year outlook that now points to increased net sales and operating profit ranges.
The company reported second quarter 2026 sales of €521.6 million compared with €416.5 million a year earlier. Net income was €140.2 million versus €82.5 million, with basic and diluted earnings per share from continuing...